Brain tumors
- Targeted metabolomics analyses for brain tumor marging assessment during surgery.
D Cakmakci, G Kaynar, C Bund, M Piotto, F Proust, IJ Namer, AE Cicek.
Bioinformatics 38: 3238-3244, 2022.
189_HRMAS_ExtempoRMN
- Machine learning assisted intraoperative assessment of brain tumor margins using HRMAS NMR spectroscopy.
D Cakmakci, EO Karakaslar, E Ruhland, MP Chenard, F Proust, M Piotto, IJ Namer, AE Cicek.
PLoS Computational Biology 16: e1008184, 2020.
176_HRMAS_ExtempoRMN
- Metabolomics profile of aggressive meningiomas by using high-resolution magic angle spinning nuclear magnetic resonance.
L Bender, F Somme, E Ruhland, AE Cicek, C Bund, IJ Namer.
Journal of Proteome Research 19: 292-299, 2020.
172_HRMAS_MEN
- Hypoxic environment and paired hierarchical 3D and 2D models of pediatric H3.3 mutated gliomas recreate the patient tumor complexity.
AF Blandin, A Durand, M Litzler, A Tripp, E Guérin, E Ruhland, A Obrecht, C Keime, Q Fuchs, D Reita, B Lhermitte, A Coca, C Jones, I Lelong-Rebel, P Villa, IJ Namer, M Dontenwill, D Guenot, N Entz-Werle.
Cancers 11: 1875, 2019.
170_HRMAS_PedGlioma
- What does reduced FDG uptake mean in high-grade gliomas?
C Bund, B Lhermitte, AE Cicek, E Ruhland, F Proust, IJ Namer.
Clinical Nuclear Medicine 44: 936-942, 2019.
166_HRMAS_Glioma_FDG
- An integrated genomics and metabolomics approach for defining survival time in adult oligodendrogliomas patients.
C Bund, M Guergova-Kuras, AE Cicek, FM Moussallieh, N Dali-Youcef, M Piotto, P Schneider, N Entz-Werle, B Lhermitte, MP Chenard, R Schott, F Proust, G Noël, IJ Namer.
Metabolomics 15:69, 2019.
161_HRMAS_Oligo3
- Characterization of transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1a axis inhibition.
A Nguyen, FM Moussallieh, A MacKay, AE Ciçek, A Coca, MP Chenard, N Weingertner, E Letouzé, E Guerin, E Pencreach, C Lasthaus, S Jannier, D Guenot, IJ Namer, J Chris, N Entz-Werle.
Oncotarget 8: 71597-71617, 2017.
144_HRMAS_Nguyen
- Gene expression mapping of histone deacetylases and co-factors and correlation with survival time and 1H-HRMAS metabolomics profile in human gliomas.
N Dali-Youcef, S Froelich, FM Moussallieh, S Chibbaro, G Noël, IJ Namer, S Heikkinen, J Auwerx.
Scientific Reports 5: 9087, 2015.
115_HRMAS_gliome2
- Towards improved grading of malignancy in oligodendrogliomas using metabolomics.
G Erb, K Elbayed, M Piotto, J Raya, A Neuville, M Mohr, D Maitrot, P Kehrli, IJ Namer.
Magnetic Resonance in Medicine 59: 959-965, 2008.
057_HRMAS_gliome1
